Fagron NV (FAGR.BR) stock: key figures, P/E, revenue and dividend
Health Care · Belgium · ISIN BE0003874915
Fagron NV financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 871.00 m EUR | 952.00 m EUR |
| Gross profit | 395.00 m EUR | 204.00 m EUR |
| Operating income | 129.96 m EUR | 144.98 m EUR |
| EBIT | 130.00 m EUR | 139.00 m EUR |
| Net income | 80.00 m EUR | 91.00 m EUR |
| Diluted EPS – continuing operations | 1.11 EUR | 1.24 EUR |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Fagron NV
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers, hospitals, and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
More stocks
- Kier Group PLC (KIE.L)
- Havas NV (HAVAS.AS)
- Bangchak Corporation Public Company Limited (BCP.BK)
- PDF SOLUTIONS INC (PDFS)
- Altarea SCA (ALTA.PA)
- Yipinhong Pharmaceutical Co Ltd Class A (300723.SZ)
- Shenzhen Xinhao Photoelectricity Technology Co. Ltd (301051.SZ)
- LuxNet (4979.TWO)
- KEMPER Corp (KMPR)
- ZIFF DAVIS, INC. (ZD)
- International Workplace Group PLC (IWG.L)
- China Marine Information Electronics Co Ltd (600764.SS)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.